Benefits of Genomic Testing in Immuno-oncology Clinical Trials

The Benefits of Incorporating Genomic Testing into Immuno-oncology Clinical Trials

In this video, Victor Weigman, Ph.D., Director, Translational Genomics discusses how incorporating genomic testing facilitates research and clinical trial design to realize genomics-based medicine. You’ll also learn how genomic testing expands insight into more treatment options based on a patient’s tumor classification.

More Resources

2 Essential Approaches You Should be Using Now for Minimal Residual Disease Detection in Oncology
Learn 3 Ways Anatomic Pathology Drives Advancements in Immuno-Oncology
Learn 3 Ways to Optimize Your Companion Diagnostic Strategy
View All